CRP and chronic kidney disease: On multivariate analysis, Yilmaz et al. revealed that elevated endocan levels in non-dialysis patients with CKD were significantly associated with higher high-sensitivity CRP levels, decreased flow-medicated vasodilation, and increased carotid intima–media thickness [16].